Pennine Acute Trust: Teaching Patient and Carers to Inject Chemotherapeutic Drug in the Comfort of Their Own House to Enhance Quality of Life and Avoid Unnecessary Hospital Commute and Exposure During the Pandemic
Bortezomib is recommended as an option for treatment of myeloma, a haematological malignancy. Patients, most of them elderly, had to come to the haematology day unit at least 32 times.
The haematology team have initiated a service whereby patients are taught to inject the drug in the comfort of their own house. This has had a significant positive impact on their quality of life by avoiding unnecessary hospital commutes and exposure during the pandemic, as evidenced in the patient experience survey. It has also created additional capacity on the day unit and financial profits based on cost per episode.
- Acute Care at Home Team, Southern Health and Social Care Trust: Our response to the COVID-19 pandemic — HIGHLY COMMENDED
- Mid and South Essex FT: Southend Frailty Team Surgical In Reach Project
- Norfolk and Norwich University Hospital FT: Developing an Advanced Practice Physiotherapist Role Within Acute Medicine
- Royal Bolton Hospital: One-Stop Retinal Service: Improving Care for Older People
- South London and Maudsley FT: Improving Safety Through the Increased Provision of Therapeutic Activity - an MDT Approach
- Stockport FT: The Acute Frailty Service
- Wiltshire Health and Care: Virtual Wards for Care Homes - Improving Care for Older People
Winners of HSJ Patient Safety Awards 2021 revealed
- Currently reading
HSJ Patient Safety Awards 2021: Improving Care for Older People Initiative of the Year